B cells are a subtype of lymphocyte. They form part of the adaptive immune response and mediate humoral immunity. B cells can produce high-affinity antibodies and generate immunological memory.
B cells are a type of white blood cell. They make antibodies -- proteins that fight viruses and bacteria. B cells normally can’t cross from your blood into your brain or spinal cord. If you have ...
Diffuse large B-cell lymphoma (DLBCL) is a cancer of the B cells of the lymphatic system. B cells are responsible for producing antibodies, which are highly specific proteins that fight against ...
B-cell therapy (also called B-cell depletion therapy) is a treatment for people with multiple sclerosis (MS). It targets certain cells -- called B cells -- that can damage nerve fibers in your ...
It is possible that AtLP represent multiclonal B cells, T cells or NK-cell lymphoproliferative processes in which there is an existence of occult abnormal B-cell, T-cell or NK-cell clones.
Background: Both plasmacytoid dendritic cells (pDCs) and B cells play pivotal roles in various autoimmune diseases, such as systemic lupus erythematosus (SLE), systemic sclerosis, and rheumatoid ...
Stem cells are specialized cells that have the potential to develop into not one but many different types of cell. They are unlike any other cell for three specific reasons: They are unspecialized, ...
Nov. 4, 2024 — Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help accelerate new biotherapies and heal complex disease ...
Nov. 5, 2024 — New research from reveals that the gut microbiome regulates the body's diurnal (day-night) rhythms in stress hormones. Depletion of gut microbiota ... Not the Usual Suspects ...
Correspondence to: Professor R J Looney, University of Rochester, 601 Elmwood Avenue, Rm G-6454, Rochester, NY 14642, USA; John_Looney{at}URMC.Rochester.edu B cells are by definition the source of all ...
Molson Coors Beverage Co. Cl A 0.37% $11.76B Molson Coors Beverage Co. Cl B 4.99% $11.76B ...